Clinical Trials Logo

Crush Injury clinical trials

View clinical trials related to Crush Injury.

Filter by:
  • None
  • Page 1

NCT ID: NCT06310265 Recruiting - Anesthesia Clinical Trials

Our Anesthesia Experiment Applied to Child Earthquake Victims in the February 6, 2023 Earthquake

Start date: March 12, 2024
Phase:
Study type: Observational

The study aimed to investigate anesthesia management of pediatric patients in the Ankara Bilkent City Hospital during the earthquake disaster of February 6.

NCT ID: NCT06003166 Not yet recruiting - Clinical trials for Peripheral Nerve Injury

4-AP Peripheral Nerve Crossover Trial

Start date: April 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the role of single dose 4-aminopyridine (4-AP) on the diagnosis of severing vs non-severing nerve injury after peripheral nerve traction and/or crush injury. The investigational treatment will be used to test the hypothesis that 4-aminopyridine can speed the determination of nerve continuity after peripheral nerve traction and/or crush injuries allowing the identification of incomplete injuries earlier than standard electrodiagnostic (EDX) and clinical assessment. Participants will be randomized to one of two groups to determine the order of treatment they receive (drug and placebo vs placebo and drug). Participants will undergo baseline testing for nerve assessment, receive either drug or placebo based on randomization and undergo hourly sensory and motor evaluation, EDX testing and serum 4AP levels for three hours after dosing. Participants will then repeat this with the crossover arm.

NCT ID: NCT04049721 Withdrawn - Crush Injury Clinical Trials

Use of Hyperbaric Oxygen Therapy for the Treatment of Crush Injuries

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether using hyperbaric oxygen (HBO) improves wound healing for patients who have a crush injury. The comparison of the prospective intervention group to the retrospective matched cohort aims to show that HBO can improve wound healing and decrease poor outcomes for patients with crush injuries. The information gained from this small study will serve as a basis for a follow-up prospective, randomized control trial to further delineate the role of HBO in a larger patient population.